Literature DB >> 7925459

Structural comparison of phospholipase-A2-binding regions in phospholipase-A2 receptors from various mammals.

K Higashino1, J Ishizaki, J Kishino, O Ohara, H Arita.   

Abstract

We determined the nucleotide sequence of a mouse cDNA encoding the receptor for pancreatic group I phospholipase A2 (PLA2-I). Interspecies structural comparison of the mouse receptor with bovine PLA2-I receptor, whose structure had been clarified, revealed that the fourth carbohydrate-recognition domain (CRD)-like domain (CRD-like 4) was the most conserved among the domains in the PLA2-I receptor, suggesting the functional importance of CRD-like 4. A transient expression experiment with a truncated form of the receptor consisting of three CRD-like domains, from the third to the fifth, demonstrated that the PLA2-I-binding site of the receptor is constituted from these three CRD-like domains, supporting the functional indispensability of CRD-like 4 in the receptor. Since the PLA2-I-binding region was thus assigned to be CRD-like domains 3-5, we further analyzed the structures of the PLA2-I-binding regions in the PLA2-I receptors from the rat, rabbit and human. Furthermore, the obtained PLA2-I receptor cDNA fragments from these animals made it possible to examine the tissue expression patterns of this receptor in various mammals. The results, together with the results of the genomic structural analysis of this gene, indicated that a PLA2 receptor recently characterized by Lambeau et al. [Lambeau, G., Ancian, P., Barhanin, J. & Lazdunski, M. (1994) J. Biol. Chem. 269, 1575-1578] is a rabbit counterpart of the PLA2-I receptor although these two PLA2 receptors have distinctive PLA2-binding specificities.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925459     DOI: 10.1111/j.1432-1033.1994.00375.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Proliferative effect of ammodytin L from the venom of Vipera ammodytes on 208F rat fibroblasts in culture.

Authors:  S Rufini; M P Cesaroni; N Balestro; P Luly
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

2.  Biochemical characterization and pharmacological properties of a phospholipase A2 myotoxin inhibitor from the plasma of the snake Bothrops asper.

Authors:  S Lizano; B Lomonte; J W Fox; J M Gutiérrez
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

Review 3.  The role of secretory phospholipase A₂ in the central nervous system and neurological diseases.

Authors:  Tatsurou Yagami; Yasuhiro Yamamoto; Hiromi Koma
Journal:  Mol Neurobiol       Date:  2013-10-10       Impact factor: 5.590

4.  Molecular modeling of Gly80 and Ser80 variants of human group IID phospholipase A2 and their receptor complexes: potential basis for weight loss in chronic obstructive pulmonary disease.

Authors:  Mohd Imran Khan; Ashish Kumar Gupta; Domada Ratna Kumar; Manoj Kumar; Abdul Samarth Ethayathulla; Gururao Hariprasad
Journal:  J Mol Model       Date:  2016-09-01       Impact factor: 1.810

5.  Proper sorting of the cation-dependent mannose 6-phosphate receptor in endosomes depends on a pair of aromatic amino acids in its cytoplasmic tail.

Authors:  A Schweizer; S Kornfeld; J Rohrer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

6.  Release of secretory phospholipase A2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion.

Authors:  A Matsuzawa; M Murakami; G Atsumi; K Imai; P Prados; K Inoue; I Kudo
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

7.  Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.

Authors:  N D Quach; J N Mock; N E Scholpa; M W Eggert; C Payré; G Lambeau; R D Arnold; B S Cummings
Journal:  Mol Pharm       Date:  2014-09-22       Impact factor: 4.939

8.  Anti-Phospholipase A2 Receptor Autoantibody: A New Biomarker for Primary Membranous Nephropathy.

Authors:  Quansheng Zhu
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2016-02

9.  The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation.

Authors:  Marc Xipell; Lida M Rodas; Jesús Villarreal; Alicia Molina; Johanna Reinoso-Moreno; Miquel Blasco; Esteban Poch; Fritz Diekmann; Jose M Campistol; Luis F Quintana
Journal:  Clin Kidney J       Date:  2017-11-22

10.  Association between PLA2R1 rs4664308 and susceptibility to idiopathic membranous nephropathy: Protocol for a systematic review and meta-analysis of case-control studies.

Authors:  Jing Yi Qiu; Xuan Gao Wu; Ting Zhang; Sunmin Park
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.